International, trade and IP
To secure its position as a life science superpower, the UK will need to increase its influence on the global stage by providing international leadership on issues of importance to the life science industry. Furthermore, it is vital that the UK’s domestic policies ensure that it can remain competitive versus other leading life science hubs.
The fundamental role of IP for protecting and promoting UK scientific innovation and securing the UK’s ambition to be a life science super power
The UK’s international trading relationships with existing and future partners is fundamental to the continued success of the life sciences and sustainable, resilient supply of medicines for the NHS.
When medicines are made, they have to be checked by the manufacturers for safety and quality in a process known as batch testing. Countries with similar high standards and regulatory checks often agree a “mutual recognition agreement” (MRA) on these batch tests, so that companies don’t have to repeat the testing when a medicine crosses a border.
International, trade and IP publications
-
Facilitating trade in health products through international manufacturing recognition and harmonisation policy
The UK can bolster its position as a leader in life sciences by charting a pragmatic approach towards, and engaging purposefully with, a global recognition policy for manufacturing.
-
Building the UK’s international research collaborations
International research collaborations are fundamental to the discovery and early development of new medicines and vaccines.
-
WTO Twelfth Ministerial Conference: A Critical Opportunity to Strengthen the Global Trade and Health Agenda
The WTO’s Twelfth Ministerial Conference (MC12) presents an opportunity for WTO members to formalize and pursue a robust trade and health agenda that builds on these principles and further strengthens the open and rules-based international trading system in response to COVID-19 and future health crises.